Results 211 to 220 of about 112,890 (268)
Some of the next articles are maybe not open access.
Urine screening for metabolic disease in newborn infants
The Journal of Pediatrics, 1980A new method for urine screening for metabolic disease in newborn infants is described. A battery of bacterial inhibition assays to test urine-impregnated filter paper from 3- to 4-week-old infants for amino acids, purines, and pyrimidines was used. We were able to establish the accuracy and efficiency of the method by examining 289 unknown specimens ...
T D, Paul, E W, Naylor, R, Guthrie
openaire +2 more sources
Hemoglobinuria associated with hemolytic disease of the newborn infant
The Journal of Pediatrics, 1967An infant with ABO incompatibility and glucose-6-phosphate dehydrogenase deficiency developed severe intravascular hemolysis leading to hemoglobinuria in the immediate neonatal period. Severe intravascular hemolysis with resultant hemoglobinuria is rare in ABO hemolytic disease of the newborn.
J J, Angella, E N, Prieto, B J, Fogel
openaire +2 more sources
Occlusive vascular disease in asphyxiated newborn infants
The Journal of Pediatrics, 1984Six full-term severely asphyxiated newborn infants underwent evaluation with digital intravenous angiography. All infants were comatose and flaccid and had seizures, depressed brainstem function, and signs of intracranial hypertension. An initial brain CT scan revealed diffuse hypodensities and compressed ventricles.
T M, Voorhies +4 more
openaire +2 more sources
Central Nervous System Disease in a Newborn Infant
Archives of Pediatrics & Adolescent Medicine, 1968THE POSSIBLE etiology of central nervous system (CNS) disease in a newborn infant is discussed by three physicians. A representative case is presented. This communication is the result of a clinical conference at the Childrens Hospital of Los Angeles. Report of a Case History.
H T, Wright, G, Reed, B H, Landing
openaire +2 more sources
Phototherapy in ABO hemolytic disease of the newborn infant
The Journal of Pediatrics, 1971Phototherapy for ABO hemolytic disease of the newborn infant usually reduces orprevents a further rise in serum bilirubin levels. In light-treated infants, peak bilirubin concentrations do not occur after the third day of life and exceed 20 mg. per cent in only 10 per cent of the infants.
E, Kaplan +3 more
openaire +2 more sources
Skin disease of the newborn infant
The Journal of Pediatrics, 1943Summary 1. A case of skin disease in an infant is presented with the clinicaland the post-mortem findings. 2. A discussion of the relation of pemphigus neonatorum, Ritter'sdisease, and Leiner's disease is presented, and consideration is given to the possible underlying causes.
openaire +1 more source
The spectrum of ABO hemolytic disease of the newborn infant
The Journal of Pediatrics, 1979A series of 1,704 infants of blood group O mothers have been studied to determine the relation between the degree of red cell sensitization and the cord hemoglobin and bilirubin concentrations. The infants with blood group A or B had significantly higher cord bilirubin and lower cord hemoglobin concentrations than the group O babies.
L, Desjardins +4 more
openaire +2 more sources
CLINICAL EXPERIENCE WITH HEMOLYTIC DISEASE OF NEWBORN INFANTS
Journal of the American Medical Association, 1957The results achieved in caring for 251 infants with hemolytic disease secondary to Rh blood group incompatibility varied significantly according to the infants' age when first available for treatment. Treatment was aimed to maintain the total serum bilirubin level below 20 mg. per 100 ml. during the first five days of life.
openaire +2 more sources
Screening Newborn Infants for Disease
Perspectives in Biology and Medicine, 1975Paul J. Benke, Will H. Blackwell
openaire +2 more sources
In Utero Disease and the Newborn Infant
Advances in Pediatrics, 1970R E, Behrman +3 more
openaire +2 more sources